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Justicia gendarussa methanolic leaf extracts from five different locations in the Southern region of Peninsular Malaysia and two
flavonoids, kaempferol and naringenin, were tested for cytotoxic activity. Kaempferol and naringenin were two flavonoids detected
in leaf extracts using gas chromatography-flame ionization detection (GC-FID). The results indicated that highest concentrations
of kaempferol and naringenin were detected in leaves extracted from Mersing with 1591.80mg/kg and 444.35mg/kg, respectively.
Positive correlationswere observed between kaempferol and naringenin concentrations in all leaf extracts analysedwith the Pearson
method. The effects of kaempferol and naringenin from leaf extracts were examined on breast cancer cell lines (MDA-MB-231 and
MDA-MB-468) using MTT assay. Leaf extract from Mersing showed high cytotoxicity against MDA-MB-468 and MDA-MB-231
with IC
50
values of 23 𝜇g/mL and 40 𝜇g/mL, respectively, compared to other leaf extracts. Kaempferol possessed high cytotoxicity
against MDA-MB-468 and MDA-MB-231 with IC
50
values of 23 𝜇g/mL and 34 𝜇g/mL, respectively. These findings suggest that the
presence of kaempferol in Mersing leaf extract contributed to high cytotoxicity of both MDA-MB-231 and MDA-MB-468 cancer
cell lines.
1. Introduction
Breast cancer is the second largest cancer after lung cancer
in the world and the most common malignancy among
women [1]. In Malaysia, the most frequent cancers are breast
cancer (18.1%), colorectal cancer (12.3%), and lung cancer
(10.2%); these three cancers affect both women and men [2].
Currently, the most common approaches for treating human
breast cancer include surgery, radiotherapy, hyperthermia,
hormone therapy, and chemotherapy [3].
Breast cancers can be classified by stage, pathology,
grade, and expression of oestrogen receptor (ER), proges-
terone receptor (PR), or human epidermal growth factor
receptor (Her2/neu) [4]. The two types of breast cancer
cells that have gained interest among investigators and
medical research laboratories are MDA-MB-231 and MDA-
MB-468. MDA-MB-231 cells are characterised as ER-, PR-,
and Her2/neu-negative/basal-B mammary carcinoma, while
MDA-MB-468 cells are characterised as ER-, PR-, and Her2/
neu-negative/basal-A mammary carcinoma [4]. MDA-MB-
231 and MDA-MB-468 cells were derived from the pleural
effusions of 51-year-old female patients. MDA-MB-231 cells
were derived from a Caucasian female, while MDA-MB-468
cells were derived from an African American female [5–7].
There is strong social interest in natural remedies, and
more than 80% of the world population considers traditional
medicine as their source of primary health care [8]. Indeed,
there has been a worldwide effort to discover new anticancer
agents from medicinal plants, and various experimental
models of natural products have resulted in anticancer agents
[9, 10].
One of the potential medicinal plants that is being
investigated in our laboratory is J. gendarussa, which is
also known by its common name Gendarussa. This plant
is a member of the Acanthaceae family that can be found
ubiquitously in many countries, including Indonesia, Sri
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Lanka, India, and Malaysia [11]. The roots and leaf extracts
of J. gendarussa have been demonstrated to treat chronic
rheumatism, inflammation, bronchitis, headache, arthri-
tis, vaginal discharges, dyspepsia, eye disease, and fever
[12].
Previous reports demonstrated that J. gendarussa leaf
extracts have been used traditionally as a male contraceptive
agent by several ethnic groups in the central part of Papua,
Indonesia. This extract is able to inhibit mouse spermatozoa
penetration of mice ovum [13]. J. gendarussa methanolic
leaves and root extracts showed cytotoxic activity against
brine shrimp in the brine shrimp lethality assay with IC
50
values of 48.71 𝜇g/mL and 93.25 𝜇g/mL, respectively [14]. In
addition, J. gendarussa leaves and stem extracts were reported
to have anticancer, antioxidant, antibacterial, antifungal,
antiangiogenic, anthelmintic, and hepatoprotective activities
[15–23].
Phytochemical studies on leaves from J. gendarussa
revealed the presence of flavonoids, alkaloids, triterpenoidal
saponins, amino acids, aromatic amines, stigmasterol, and
lupeol [18, 24–27]. Our previous study on green callus and
in vitro leaf extracts of J. gendarussa detected two flavonoids,
that is, kaempferol and naringenin using GC-FID [28]. Both
flavonoids were also detected in themethanolic leaf extract of
J. gendarussa using the same method [29]. Bioactivity studies
on both flavonoids found that it exhibited strong antioxidant
and inhibitory effects on cholesterol in HepG2 cancer cells
[30–32]. Kaempferol also inhibited pancreatic cancer cell
(MIAPaCa-2 and Panc-1) proliferation, induced cancer cell
apoptosis, and prevented arteriosclerosis [30, 33]. Naringenin
demonstrated cytotoxic effects against breast cancer cells
(MCF-7) and suppressed apoptosis in mouse leukaemia P388
cells [34–36]. Our previous study on both flavonoids showed
strong cytotoxic activity against colonic (HT-29), cervical
(HeLa), and pancreatic (BxPC-3) cells [29].
To the best of our knowledge, this is the first study of the
effects of J. gendarussa leaf extracts against human breast can-
cer cell lines (MDA-MB-231 and MDA-MB-468). This study
was performed to screen the cytotoxic activities ofmethanolic
leaf extracts from five different locations (Mersing, Muar,
Skudai, Batu Pahat, and Pulai) in Johor and two flavonoids
(naringenin and kaempferol) against breast cancer cell lines.
The quantification of kaempferol and naringenin content in
leaf extracts of J. gendarussa using GC-FID was also carried
out.
2. Methods and Materials
2.1. Plant Materials. J. gendarussa plants were collected from
five different locations in Johor (Mersing, Muar, Skudai, Batu
Pahat, and Pulai) and maintained in a greenhouse at the
Faculty of Biosciences and Medical Engineering, Universiti
Teknologi Malaysia (UTM). The J. gendarussa plant was
identified byDr. RichardChungChengKong, senior research
officer of the Forest Research Institute of Malaysia (FRIM).
The voucher specimen (PID-100214-06) was deposited at
Herbarium Management Branch, Flora Biodiversity Pro-
gram, Forest Biodiversity Division, FRIM, Kepong, Selangor,
Malaysia.
2.2. General Chemicals. Commercial standards (kaempferol
and naringenin) were purchased from Sigma-Aldrich (Sub-
ang Jaya, Selangor, Malaysia). Tamoxifen was used as a
positive control in the MTT assay. All samples were diluted
with 0.1% of dimethylsulfoxide (DMSO), which has no effect
on cell viability [37].
2.3. Preparation of Extracts. The J. gendarussa leaves were air-
dried for 4 weeks. The dried leaves were ground into small
particles and approximately 50 g of small particles was soaked
into 1000mLofmethanol at room temperature for 72 hours in
a ratio of 1 : 20 (w/v) [10]. The mixtures were filtered through
sterile cotton and filtered again using Whatman number 1
filter paper to obtain methanolic supernatants. The filtered
methanolic extract was evaporated at 40∘C under reduced
pressure by using an EYELA N-1000 rotary evaporator
(Bohemia, NY, USA).The dried crude extract was kept at 4∘C
prior to use.
2.4. Quantification of Flavonoids in Leaf Extracts. GC-FID
and quantitative analysis were performed according to previ-
ously published method [38]. GC-FID (HP-6890N, Agilent,
USA) equipped with a HP-5 fused silica capillary column
(30.0m × 0.32mm ID × 0.25𝜇m) was used. The temperature
programmed was 100∘C held for 1 minute and then ramped
to 275∘C at 10∘C/min and held for 17 minutes at 275∘C. The
injection temperature was 275∘C. The flow rate of the carrier
gas (helium) was 1mL/min. A split ratio of 50 : 1 was used. A
quantity of 5𝜇L of leaf extract and standardswas injected.The
chromatographic data were recorded and processed using
Agilent Cerity QA-QC software.
2.5. Cell Culture. MDA-MB-231 (basal-B mammary carci-
noma) and MDA-MB-468 (basal-A mammary carcinoma)
breast cancer cell lines and CHO (Chinese hamster ovary)
normal cell line were obtained from American Type Culture
Collection (ATCC) and as a generous gift from Dr. Sale-
hhuddin Hamdan (Animal Cell Culture Laboratory, Faculty
of Biosciences and Medical Engineering, UTM). MDA-MB-
231 and MDA-MB-468 breast cancer cell lines were cultured
in Dulbecco’s modified Eagle’s medium (DMEM), while
CHO normal cells were cultured in Roswell Park Memorial
Institute 1640 (RPMI-1640) medium supplemented with 10%
v/v foetal bovine serum (FBS), 100U/mL of penicillin, and
100 𝜇g/mL of streptomycin as a complete growth medium.
Cells were maintained in 25 cm2 flasks and incubated
in a humidified incubator (CO
2
Water-Jacketed Incubator
NuAire, Fernbrook Lane, Plymouth, USA) at 37∘C with 5%
CO
2
. All materials were obtained from Gibco (Gibco, Bio-
Diagnostics, Petaling Jaya, Selangor, Malaysia).
2.6. MTTAssay. Cytotoxicity testing was performed using 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT, Sigma) according to the method reported in previous
studies [29, 39]. In this assay, cells were harvested after
reaching 80% confluence. Before starting theMTT assay, cells
were optimised at different seeding densities ranging from
2.0 × 103 cell/mL to 1.0 × 106 cell/mL in light to determine
Evidence-Based Complementary and Alternative Medicine 3
appropriate seeding number for the experiment. Each well of
the microtiter plate (96-well) was filled with 100𝜇L of cell
suspension (MDA-MB-231, MDA-MB-468, and CHO with
the seeding number; 5 × 104 cell/mL) in complete growth
medium. After 24 hours of incubation, cells were treated
with leaf extracts of different concentrations ranging from
7.81 to 1000𝜇g/mL, with a total well volume of 200𝜇L with
technical replicates. Microtiter plates were further incubated
for 72 hours with plant extracts. After 72 hours of incubation,
20𝜇L of MTT (a stock solution of 5mg/mL in PBS) was
added to each well, and the plates incubated for 4 hours
at 37∘C. Medium from each well was carefully removed
without disturbing the MTT crystals in wells. The MTT
formazan crystals were dissolved by the addition of 1M
HCl and 100mM isopropanol to each well. After solubilising
the purple formazan, absorbance was measured using a
BioRad microplate reader (Shinagawa-ku, Tokyo, Japan) at
a wavelength of 575 nm. Cytotoxic activity was recorded as
IC
50
, which is the concentration necessary to reduce the
absorbance of treated cells by 50% compared to the control
(untreated cells) [40].
2.7. Statistical Analysis. All samples were run in three repli-
cates. Data obtained were analysed using SPSS software
for Windows (SPSS 16.0 for Windows Evaluation Version
software, SPSS Inc., USA). The normality of the data was
tested using the Shapiro-Wilk test. The data were analysed
using the Independence 𝑡-test for normal data and Mann-
Whitney 𝑈 test for nonnormal data. The correlations were
analysed using the Pearson correlation test [41]. Differences
were considered to achieve significance for probability 𝑃 <
0.05.
3. Results
Phytochemical analysis of J. gendarussa leaf extracts showed
that kaempferol and naringenin were quantified from five
different locations byGC-FID. Figure 1 shows the distribution
of kaempferol and naringenin contents in leaf extracts.
In this study, cytotoxicity of J. gendarussa leaf extracts
from five different locations and flavonoids (kaempferol,
naringenin, and a mixture of kaempferol and naringenin)
were tested against breast cancer cell lines (MDA-MB-231 and
MDA-MB-468) and a normal cell line (CHO) using MTT
assay. Tamoxifen was used as a positive control. The IC
50
values obtained referred to 50% of cells inhibited by plant
extracts [42]. In a previous study, cytotoxicity was evaluated
based on IC
50
values, where IC
50
values below 20𝜇g/mLwere
considered cytotoxic, from 21 to 40𝜇g/mL were considered
weak cytotoxic, and above 40 𝜇g/mL were not considered
cytotoxic [40, 43, 44].
Table 1 represents the IC
50
values of J. gendarussa
leaf extracts, flavonoids, and tamoxifen. Overall, tamoxifen
showed cytotoxic activity against CHO and MDA-MB-231
cells with IC
50
values of 8𝜇g/mL and 12 𝜇g/mL, respec-
tively, compared to MDA-MB-468 cell with IC
50
values of
27𝜇g/mL.
Morphological changes of cells were observed under
an inverted fluorescence microscope (Nikon ECLIPSE Ti-S,
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Figure 1: Distribution of kaempferol and naringenin contents in
leaf extracts from five different locations. Each result is the mean
of 3 replicates. Error bars represent standard deviations (STDEV).
Results that are significantly different ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and
∗∗∗
𝑃 < 0.001 are marked with an asterisk.
Table 1: Comparison of IC50 values between J. gendarussa leaf
extracts, flavonoids, and tamoxifen in breast cancer cell lines.
IC50 values (𝜇g/mL)
MDA-MB-231 MDA-MB-468 CHO
Leaf extract
Mersing 40 23 28
Muar 275 160 108
Skudai 61 259 88
Batu Pahat 538 398 190
Pulai 250 299 305
Compounds
Kaempferol 34 23 14
Naringenin 238 70 21
Mixture of kaempferol
and naringenin 43 44 NT
Tamoxifen 12 27 8
NT: not tested.
Shinagawa-ku, Tokyo, Japan) (100x magnification) after 72
hours of treatment.Themethanolic leaf extracts from various
locations were used to treat MDA-MB-231 cancer cell lines
and revealed morphology changes (Figures 2(b), 2(c), 2(d),
2(e), and 2(f)) compared to nontreated cells (Figure 2(a)).
Morphological changes were revealed after methanolic
leaf extract treatment ofMDA-MB-468 cancer cell lines (Fig-
ures 3(b), 3(c), 3(d), 3(e), and 3(f)) compared to nontreated
cells (Figure 3(a)).
The morphology changes of MDA-MB-231 (Figures 4(b),
4(c), and 4(d)) and MDA-MB-468 (Figures 4(f), 4(g), and
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(d) (e) (f)
Figure 2: Morphology changes of MDA-MB-231 cells when treated with leaf extracts. (a) MDA-MB-231 cells without any treatment; (b) leaf
extract from Mersing (IC
50
: 40 𝜇g/mL); (c) leaf extract from Muar (IC
50
: 275 𝜇g/mL); (d) leaf extract from Skudai (IC
50
: 61 𝜇g/mL); (e) leaf
extract from Batu Pahat (IC
50
: 538 𝜇g/mL); and (f) leaf extract from Pulai (IC
50
: 250 𝜇g/mL). Scale bars: 100 𝜇M.
4(h)) cancer cell lines when treated with kaempferol, narin-
genin and a mixture of kaempferol and naringenin compared
to nontreated MDA-MB-231 and MDA-MB-468 cancer cell
lines (Figures 4(a) and 4(e)), respectively.
4. Discussion
Phytochemical analysis of kaempferol and naringenin in
leaf extracts from five locations was evaluated and shown
in Figure 1. The highest concentrations of kaempferol and
naringenin were found in leaf extracts from Mersing with
1591.80mg/kg and 444.35mg/kg, respectively. Positive corre-
lations were observed between kaempferol and naringenin in
all leaf extracts when analysed using the Pearson method. In
addition, there was a significant difference in the kaempferol
and naringenin distribution contents of leaf extracts fromfive
different locations.
The cytotoxicity profile of J. gendarussa leaf extracts
from five different locations and flavonoids (kaempferol,
naringenin, and a mixture of kaempferol and naringenin)
against MDA-MD-231, MDA-MB-468, and CHO cells are
shown in Table 1. The inhibitory effects of all leaf extracts
against breast cancer cell lines were decreased in a dose
dependent manner, and these trends are consistent with
previous studies [10, 42, 45, 46]. The IC
50
values of the leaf
extract from Mersing (40 𝜇g/mL) showed weak cytotoxicity,
followed by leaf extracts from Skudai (61𝜇g/mL), Batu Pahat
(250 𝜇g/mL), Muar (275𝜇g/mL), and Pulai (275𝜇g/mL)
against MDA-MB-231 breast cancer cells. IC
50
values of the
leaf extract fromMersing (23 𝜇g/mL) showed weak cytotoxi-
city, followed by leaf extracts fromMuar (160𝜇g/mL), Skudai
(259 𝜇g/mL), Batu Pahat (299 𝜇g/mL), and Pulai (398 𝜇g/mL)
against MDA-MB-468 cell lines. The percent cell viability
of leaf extracts and flavonoids was compared to the control
(untreated cell). The results demonstrate that there was a
significant difference in IC
50
values of each leaf extract against
MDA-MB-231 and MDA-MB-468 cell lines (Tables 2 and 3).
Because both flavonoids were present in high concentrations
in leaf extracts, it is suggested that cytotoxic effects were
mainly due to the presence of these flavonoids in elucidating
tumour suppressive effects.
Table 1 also shows the ability of kaempferol, naringenin,
and a mixture of kaempferol and naringenin to inhibit the
proliferation of breast cancer cell lines in this study. How-
ever, kaempferol showed weak cytotoxicity, with IC
50
values
of approximately 34 𝜇g/mL (MDA-MB-231) and 23𝜇g/mL
(MDA-MB-468). This was followed by naringenin, with
IC
50
values of approximately 238 𝜇g/mL (MDA-MB-231) and
70 𝜇g/mL (MDA-MB-468). The mixture of flavonoids also
showed weak cytotoxicity, with IC
50
values of approximately
43 𝜇g/mL (MDA-MB-231) and 44𝜇g/mL (MDA-MB-468). It
is proposed that kaempferol associated highest cytotoxicity
against breast cancer cell lines compared to naringenin and
a mixture of kaempferol and naringenin. Table 4 shows that
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Figure 3: Morphological changes of MDA-MB-468 cells when treated with leaf extracts. (a) MDA-MB-468 cells without any treatment; (b)
leaf extract from Mersing (IC
50
: 23 𝜇g/mL); (c) leaf extract from Muar (IC
50
: 160𝜇g/mL); (d) leaf extract from Skudai (IC
50
: 259 𝜇g/mL); (e)
leaf extract from Batu Pahat (IC
50
: 398 𝜇g/mL); and (f) leaf extract from Pulai (IC
50
: 299 𝜇g/mL). Scale bars: 100𝜇M.
there was a significant difference between the control with
MDA-MB-231 andMDA-MB-468 treated cells for IC
50
values
of flavonoids, except for kaempferol against MDA-MD-231.
The leaf extracts and flavonoids also showed low cytotoxicity
toward CHO cells (Table 1).This indicates a lack of selectivity
in the cytotoxicity between cancer and normal cells by the leaf
extracts and flavonoids [47].
However, the current study also has contradictory results.
It is shown in Figures 1, 2, and 3 that treated cells showedmore
prominent growth inhibition and shrinkage of the cells when
compared to untreated cells that remained confluent. Many
factors may have influenced these contradictory results.
The plant source, environmental and geographic conditions,
cell lines, and seeding number used in this study were
completely different from those used in publishedworks [48–
50]. Thus, the results presented in this study were not totally
in agreement with published [40, 43, 44] statements of IC
50
values ranging toward crude extracts. Moreover, different
plant extracts exhibited different effects on the proliferation
of cells according to properties of the compounds [48]. This
was because selectivity could be due to the sensitivities of cell
lines against the active compounds in crude extracts that have
a specific response [51, 52]. Overall, J. gendarussa leaf extracts
and flavonoids were considered to hold promising anticancer
effects on MDA-MB-231 and MDA-MB-468 cells.
The results of J. gendarussa leaf extract from Mersing
showed less of an effect against MDA-MB-231 compared
to MDA-MB-468 (Table 1). This suggests that the effects
of active compounds, particularly flavonoids, on MDA-MB-
231 are less cytotoxic compared to those on MDA-MB-
468 cell lines. MDA-MB-231 is an oestrogen receptor (ER-
negative) cell line that containsmore than one cell population
and is highly aggressive, invasive, and poorly differentiated
from human breast cancer cell lines [53, 54]. MDA-MB-
468 cells were most resistant to hyperacetylation and DNA
degradation by drug treatments.This suggests that theMDA-
MB-468 cell line has a phenotypic difference from and is
less invasive than MDA-MB-231 [4]. In a previous study, T.
crispa and M. calabura methanolic leaf extracts produced
IC
50
values of approximately 52.5 𝜇g/mL and more than
100 𝜇g/mL, respectively [10, 42]. However, J. gendarussa leaf
extract from Mersing showed an IC
50
value of 40 𝜇g/mL,
exhibiting higher toxicity compared to other leaf extracts. It
is suggested that J. gendarussa leaf extract from Mersing has
cytotoxicity potential against MDA-MB-231 cells compared
to other plant leaf extracts.
Based on the collected data, kaempferol showed the
highest cytotoxicity against MDA-MB-468, followed by
MDA-MB-231 and naringenin. These results are consistent
with other studies showing weak inhibition of naringenin
by other flavonoids [55]. A previous study reported that
flavonoidswith hydroxyl substituents at the 4󸀠 and 7 positions
were invariably oestrogenic, and an additional hydroxyl
group at the 5th position increased estrogenic activity [56].
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Figure 4: Morphology of MDA-MB231 and MDA-MB-468 cells when treated with kaempferol, naringenin and a mixture of kaempferol
and naringenin. (a) MDA-MB-231 cells without any treatment, control; (b) MDA-MB-231 cells treated with kaempferol (IC
50
: 34 𝜇g/mL); (c)
MDA-MB-231 cells treated with naringenin (IC
50
: 238 𝜇g/mL); (d) MDA-MB-231 cells treated with a mixture of kaempferol and naringenin
(IC
50
: 43 𝜇g/mL); (e)MDA-MB-468 cells without any treatment, control; (f)MDA-MB-468 cells treatedwith kaempferol (IC
50
: 23 𝜇g/mL); (g)
MDA-MB-468 cells treated with naringenin (IC
50
: 70 𝜇g/mL); (h) MDA-MB-468 cells treated with a mixture of kaempferol and naringenin
(IC
50
: 44𝜇g/mL). Scale bars: 100 𝜇M.
The present study supports this claim [56]. Previous work
also demonstrated that naringenin showed a stronger oestro-
genicitywhen tested onBT-474 humanbreast cancer cell lines
[57]. It is plausible to suggest that both flavonoids contribute
strong oestrogenic potency to the inhibition of oestrogen-
independent breast cancer cells, MDA-MB-231 and MDA-
MB-468.
Table 1 also shows the cytotoxicity of J. gendarussa
leaf extracts, flavonoids, and tamoxifen on a normal cell
line (CHO). CHO cells were a positive control used for
comparison with the cytotoxicity activity on MDA-MB-231
and MDA-MB-468 breast cancer cell lines. Comparisons of
J. gendarussa leaf extracts, flavonoids, and tamoxifen were
performed in terms of IC
50
values between breast cancer
and normal cell lines. Tamoxifen was demonstrated to be
cytotoxic to CHO cell lines (IC
50
< 20𝜇g/mL) in this study.
Although the IC
50
values of leaf extracts and flavonoids were
not as low as tamoxifen, they had low toxicity against CHO
cells. Due to its high toxicity in CHO cells, the continuous
use of tamoxifen can cause adverse side effects [58]. If
these results also occur in vivo, these leaf extracts would be
considered safe for human consumption and could be used
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for further toxicity and clinical studies. Hence, the use of leaf
extracts and flavonoids as anticancer agents in combination
with other therapeutic drugs may reduce the adverse effects
of drugs. Therefore, more comprehensive studies involving
animal and clinical investigations are required.
5. Conclusion
In conclusion, J. gendarussa leaf extract from Mersing and
kaempferol were considered cytotoxic against MDA-MB-
231 and MDA-MB-468 compared to other leaf extracts and
naringenin. Leaf extract fromMersing showed high contents
of kaempferol and naringenin compared to other leaf extracts
when quantified usingGC-FID.Our results suggest that there
is a correlation between the presence of kaempferol in the leaf
extract from Mersing with the level of cytotoxicity against
both breast cancer cell lines. These data will be beneficial
to other researchers and validate the potential use of J.
gendarussa leaves as novel anticancer agents.
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